-
公开(公告)号:US20110160212A1
公开(公告)日:2011-06-30
申请号:US12979571
申请日:2010-12-28
申请人: Weibo Wang , Tongshuang Li
发明人: Weibo Wang , Tongshuang Li
IPC分类号: A61K31/53 , C07D401/04 , A61P3/08 , A61P3/10
CPC分类号: C07D401/04
摘要: Provided are certain dipeptidyl peptidase inhibitors, pharmaceutical compositions thereof, and methods of use therefor.
摘要翻译: 提供某些二肽基肽酶抑制剂,其药物组合物及其用途的方法。
-
公开(公告)号:US07608723B2
公开(公告)日:2009-10-27
申请号:US11251440
申请日:2005-10-14
申请人: Rustum S. Boyce , Yi Xia , Hongyan Guo , Kris G. Mendenhull , Annette O. Walter , Weibo Wang
发明人: Rustum S. Boyce , Yi Xia , Hongyan Guo , Kris G. Mendenhull , Annette O. Walter , Weibo Wang
IPC分类号: C07D209/10 , C07D235/14 , A61K31/33
CPC分类号: C07D403/12 , C07D209/14 , C07D235/14 , C07D401/12 , C07D403/04 , C07D403/14
摘要: The present invention relates to new indole and benzimidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula:
摘要翻译: 本发明涉及新的吲哚和苯并咪唑化合物及其药学上可接受的盐,酯或前药,新化合物的组合物和药学上可接受的载体,以及新化合物的用途。 本发明的化合物具有以下通式:
-
公开(公告)号:US20090028858A1
公开(公告)日:2009-01-29
申请号:US12242360
申请日:2008-09-30
IPC分类号: A61K39/395 , C07D215/04 , A61P35/00 , A61K31/47
CPC分类号: C07D215/12 , C07D215/18
摘要: The present invention relates to new substituted quinoline compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula:
摘要翻译: 本发明涉及新的取代喹啉化合物及其药学上可接受的盐,酯或前药,新化合物与药学上可接受的载体的组合物,以及新化合物的用途。 本发明的化合物具有以下通式:
-
公开(公告)号:US20090001154A1
公开(公告)日:2009-01-01
申请号:US11854057
申请日:2007-09-12
申请人: Weibo Wang
发明人: Weibo Wang
IPC分类号: G06F17/00
CPC分类号: H04N1/444 , G03G15/5087 , G03G15/5091 , G03G21/046 , H04N1/00347 , H04N1/00846 , H04N1/4406 , H04N2201/0039 , H04N2201/0091 , H04N2201/0094 , H04N2201/3246 , H04N2201/3278
摘要: An image forming apparatus connected to a network including a reading device configured to read a document having ID data; a storage device configured to store a document data that is transmitted by the reading device; an analyzing device configured to analyze the document data and to determine an image forming apparatus that formed the document using the ID data; a communication device configured to transmit the ID data to the image forming apparatus found by the analyzing device; and an image generating device configured to generate the document data on a media when said communication device receives an authorization to copy sent by the image forming apparatus that is found by the analyzing device.
摘要翻译: 一种连接到网络的图像形成装置,包括被配置为读取具有ID数据的文档的读取装置; 存储装置,被配置为存储由所述读取装置发送的文档数据; 分析装置,被配置为分析文档数据并且确定使用ID数据形成文档的图像形成装置; 通信装置,被配置为将ID数据发送到由分析装置找到的图像形成装置; 以及图像生成装置,被配置为当所述通信装置接收到由所述分析装置发现的图像形成装置发送的复制授权时,在媒体上生成文档数据。
-
35.
公开(公告)号:US07326711B2
公开(公告)日:2008-02-05
申请号:US10870707
申请日:2004-06-17
申请人: Weibo Wang , Ryan N. Constantine , Liana Marie Lagniton , Sabina Pecchi , Matthew T. Burger , Manoj C. Desai
发明人: Weibo Wang , Ryan N. Constantine , Liana Marie Lagniton , Sabina Pecchi , Matthew T. Burger , Manoj C. Desai
IPC分类号: A61K31/519 , A61K35/00 , C07D487/04
CPC分类号: C07D471/04
摘要: Pyridin[1,2-a]pyrimidinyl compounds, pharmaceutically acceptable salts, and prodrugs thereof; compositions that include a pharmaceutically acceptable carrier and one or more of the pyridino[1,2-a]pyrimidinyl compounds, either alone or in combination with at least one additional therapeutic agent. Methods of using the pyridino[1,2-a]pyrimidinyl compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases.
摘要翻译: 吡啶并[1,2-a]嘧啶基化合物,其药学上可接受的盐和前药; 包括药学上可接受的载体和一种或多种吡啶并[1,2-a]嘧啶基化合物的组合物,单独或与至少一种另外的治疗剂组合。 单独或与至少一种其它治疗剂组合使用吡啶并[1,2-a]嘧啶基化合物在预防或治疗增殖性疾病中的方法。
-
公开(公告)号:US20060084687A1
公开(公告)日:2006-04-20
申请号:US11251440
申请日:2005-10-14
申请人: Rustum Boyce , Hongyan Guo , Kris Mendenhall , Annette Walter , Weibo Wang , Yia Xia
发明人: Rustum Boyce , Hongyan Guo , Kris Mendenhall , Annette Walter , Weibo Wang , Yia Xia
IPC分类号: A61K31/433 , A61K31/427 , A61K31/422 , A61K31/42 , A61K31/4184 , A61K31/416 , C07D417/02 , C07D413/02 , C07D403/02
CPC分类号: C07D403/12 , C07D209/14 , C07D235/14 , C07D401/12 , C07D403/04 , C07D403/14
摘要: The present invention relates to new indole and benzimidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula:
-
公开(公告)号:US20050228002A1
公开(公告)日:2005-10-13
申请号:US11100923
申请日:2005-04-06
申请人: Weibo Wang , Ryan Constantine , Liana Lagniton
发明人: Weibo Wang , Ryan Constantine , Liana Lagniton
IPC分类号: A61K31/519 , C07D239/36 , C07D471/04 , C07D489/02
CPC分类号: C07D471/04 , C07D239/36
摘要: The present invention relates to compounds that are useful for treating cellular proliferative diseases, for treating disorders mediated, at least in part, by KSP, and for inhibiting KSP. The invention also related to pharmaceutical compositions comprising such compounds, methods of treating cancer by the administration of such compositions, and processes for the preparation of the compounds. Compounds of the invention have the following formula:
摘要翻译: 本发明涉及可用于治疗细胞增殖性疾病,用于治疗至少部分由KSP介导的病症和用于抑制KSP的化合物。 本发明还涉及包含这些化合物的药物组合物,通过施用这些组合物治疗癌症的方法,以及制备化合物的方法。 本发明化合物具有下式:
-
公开(公告)号:US20050209254A1
公开(公告)日:2005-09-22
申请号:US10996814
申请日:2004-11-24
申请人: Weibo Wang , Liana Lagniton , Ryan Constantine , Manoj Desai
发明人: Weibo Wang , Liana Lagniton , Ryan Constantine , Manoj Desai
IPC分类号: A61K31/517 , C07D239/40 , C07D239/90 , C07D401/06 , C07D43/02
CPC分类号: C07D401/06 , C07D239/90
摘要: Quinazolinone compounds, pharmaceutically acceptable salts, and prodrugs thereof; compositions that include a pharmaceutically acceptable carrier and one or more of the quinazolinone compounds, either alone or in combination with at least one additional therapeutic agent. Methods of using the quinazolinone compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases.
摘要翻译: 喹唑啉酮化合物,其药学上可接受的盐和前药; 包括药学上可接受的载体和一种或多种喹唑啉酮化合物的组合物,单独或与至少一种另外的治疗剂组合。 单独使用喹唑啉酮化合物或与至少一种其它治疗剂组合使用的方法可用于预防或治疗增殖性疾病。
-
公开(公告)号:US08008335B2
公开(公告)日:2011-08-30
申请号:US11665956
申请日:2005-10-14
申请人: Rustum S. Boyce , Yi Xia , Hongyan Guo , Kris G. Mendenhall , Annette O. Walter , Weibo Wang
发明人: Rustum S. Boyce , Yi Xia , Hongyan Guo , Kris G. Mendenhall , Annette O. Walter , Weibo Wang
IPC分类号: A61K31/4045 , A61K31/417 , C07D209/14 , C07D235/14
CPC分类号: C07D403/12 , C07D209/14 , C07D235/14 , C07D401/12 , C07D403/04 , C07D403/14
摘要: The present invention relates to new indole and benzimidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula (I).
摘要翻译: 本发明涉及新的吲哚和苯并咪唑化合物及其药学上可接受的盐,酯或前药,新化合物的组合物和药学上可接受的载体,以及新化合物的用途。 本发明的化合物具有以下通式(I)。
-
公开(公告)号:US07939539B2
公开(公告)日:2011-05-10
申请号:US10996814
申请日:2004-11-24
IPC分类号: A61K31/517 , C07D239/88
CPC分类号: C07D401/06 , C07D239/90
摘要: Quinazolinone compounds, pharmaceutically acceptable salts, and prodrugs thereof; compositions that include a pharmaceutically acceptable carrier and one or more of the quinazolinone compounds, either alone or in combination with at least one additional therapeutic agent. Methods of using the quinazolinone compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases.
摘要翻译: 喹唑啉酮化合物,其药学上可接受的盐和前药; 包括药学上可接受的载体和一种或多种喹唑啉酮化合物的组合物,单独或与至少一种另外的治疗剂组合。 单独使用喹唑啉酮化合物或与至少一种其它治疗剂组合使用的方法可用于预防或治疗增殖性疾病。
-
-
-
-
-
-
-
-
-